Full Text
Cost-Utility Analysis of Newer HER2- Testing Technologies to Target Trastuzumab in the Adjuvant Breast Cancer Setting

Abstract

Authors

I.L. Ferrusi N.A. Kulin R. Goeree N. Leighl E.M. Pullenayegum K. Phillips D. Marshall

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×